GENESIS Biomed continues growing and adding value in biomedical sector

by GENESIS Biomed

1 year ago
GENESIS Biomed, GENESIS Tech Transfer Boost

GENESIS Biomed, a consultancy firm that specialises in early-stage R&D projects in the biomedical sector, expects to close out 2022 with record turnover of €1.6 million, up 28% from the previous yea...

The Investor Deck, the startup’s business card

by GENESIS Biomed

1 year ago
Investor Deck

The Investor Deck can be described as the business card of a entrepreneurship project where through an executive presentation, thus summarized, of between 10-15 slides the investor can obtain the esse...

Value-based medicine and Risk Sharing Agreement

by GENESIS Biomed

1 year ago
“Patient Value”, Risk sharement agreement

The development of more sophisticated and high-cost treatments with a high preponderance of advanced therapies suggests that this business model is expected to be imposed in more and more cases, imply...

Diabetic patients in rural areas will be able to be diagnosed with diabetic retinopathy in the early stages of the disease thanks to a mobile system

by GENESIS Biomed

2 years ago
diabetic retinopathy

It has been developed a software and a system based on artificial intelligence to diagnose the diabetic retinopathy, a common eye disorder in patients with type 2 diabetes, which is the leading cause ...

Law of Science, the missed opportunity for spin-off creation

by GENESIS Biomed

2 years ago
Law on Science, Technology and Innovation (Law 17/2022)

The new Law on Science, Technology and Innovation (Law 17/2022) does not remove the obligation for public institutions to participate in a spin-off if they want to lift the incompatibilities of resear...

10 projects from the Xartec Salut network are advised by GENESIS Biomed within the framework of the Venture Builder programme

by GENESIS Biomed

2 years ago
Venture Builder Programme, Xartec Salut

Within the framework of the Venture Builder Programme, a mechanism promoted by Xartec Salut to accelerate the creation of spin-off companies, GENESIS Biomed has collaborated during the years 2021 and ...

FiSPlat, a primary care tool for liver fibrosis screening

by GENESIS Biomed

2 years ago
FiSPlat, fibrosis hepática, cirrosis hepática, EIT Health

ASPY Prevención has started a collaboration with Hospital Clínic de Barcelona within the framework of the European project FiSPlat, financed by EIT Health. Within the project, ASPY Prevención will ...

Negotiating a Round in the health sector

by GENESIS Biomed

2 years ago
Venture Capital

Dialogue with investors is no easy task for entrepreneurs in the healthcare sector. We will focus more on how to negotiate a round in the health Venture Capital investor sector in this article,

Crowdfunding and Venture Capital: two complementary systems for private funding in the health sector

by GENESIS Biomed

2 years ago
crowdfunding, Capital Cell, Venture Capital

As we already know, public funding is not enough to cover the entire life cycle of a company in the health sector. In fact, it is becoming increasingly common for public funding sources to contain in ...

Public-private collaboration in the health and research environment and some of its successes in which GENESIS Biomed has collaborated

by GENESIS Biomed

2 years ago
“Innovation Support Units” (UAI), agreements, alliances and public-private collaborations, Corify Care, Telara Pharma, THYTECH

The main objective of any innovation generated by a health research centre or public hospital is to reach the market as soon as possible, i.e., to ensure that potential users, be they doctors, patient...

GENESIS Biomed and FI Group create GENESIS Tech Transfer Boost, a new investment vehicle that will invest in early stage projects from healthcare research

by GENESIS Biomed

2 years ago
GENESIS Tech Transfer Boost

The consultancy firms GENESIS Biomed and FI Group, leaders in biomedical strategic consultancy and in advising on the financing of R&D&I and the management of calls for public grants and funding, res...

Interview Jordi Ortiz – Quality Manager and Senior Consultant at GENESIS Biomed

by GENESIS Biomed

2 years ago
Genesis Biomed

Jordi Ortiz: “We have designed the implementation of annual quality plans that will allow us to reach the standards required by ISO9001”. Jordi Ortiz holds a degree in Chemistry (specialising in ...